Emeis share falls and threatens its €12.66 support level
Emeis erases much of the rebound posted last Monday over two sessions, as the share remains deeply underwater below its three moving averages in a European market itself trending downward. The monthly performance, now down more than 12%, illustrates the persistent pressure on the share since this summer.
A decline of 3.34% that intensifies the downward trend of the past four weeks
Emeis closes at €12.75, down 3.34% compared to the previous day (€13.19), ranking among the steepest declines of the SBF 120 at the end of this session. The movement extends a weakened dynamic: over the week, the share loses 7.61%, and over the month, the decline exceeds 12%. These figures bring the price very close to the €12.66 support level, which the share is now flirting with a gap of less than 1%. On the resistance side, the €14.56 threshold is far away, more than 14% above the current price.
The overall configuration remains unfavorable: the price is trading below the 20-day MA at €13.87, the 50-day MA at €14.03 and the 200-day MA at €14.04, with gaps ranging between 8% and over 9% on each. The RSI at 41 does not yet signal an outright oversold zone, but reflects selling pressure that is gradually building. The CAC 40 and SBF 120 each finished slightly lower at their respective close, which amplified the challenging context for French equities this afternoon.
Monday's rebound absorbed, Q1 2026 fundamentals struggling to support the share price
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The 2.5% rebound recorded on Monday, August 31, one of the best performances of the SBF 120 that day, thus proved ephemeral. In less than two sessions, the gain was entirely erased, and the share falls back below its Friday level. Over one year, Emeis still shows a gain of 7.5%, but this cushion is eroding over the weeks, with short-term momentum contradicting the annual dynamic.
As a reminder, when Q1 2026 results were published on May 7, 2026, the company reported organic growth of 6.3%, supported by rising occupancy rates. This operational dynamic was not sufficient to anchor the share durably in an upward phase, with valuation remaining under pressure. The €12.66 support level, now almost reached, is concentrating attention in the short term.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 9M 2026
Key reported figures
Revenue: 4 543 millions d'euros
Quarterly revenue: 4 543 millions d'euros
Revenue growth: 3,5 %
Guidance from the release
« Les tendances observées lors des 9 premiers mois de l'année 2026 confortent emeis dans l'atteinte des objectifs pour 2026, objectifs par ailleurs relevés fin juillet. »
Risks mentioned
Health crises linked to flu outbreaks and heat waves requiring proactive management
Macroeconomic uncertainty and risk of return to inflation impacting operating expenses
Dependency on continued execution of operational efficiency programs such as the Boost initiative in France
Opportunities identified
Strong like-for-like revenue growth of +6.0% driven by improved occupancy rates and favorable pricing effects
Average occupancy rate now above 90% with +2.9 pts annual increase, particularly strong in nursing homes (+3.1 pts)
Structural demographic tailwind with European senior population aged 85+ expected to grow over 30% in next 10 years
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
